Cell therapy upstream processing and materials

CELL AND GENE THERAPY INSIGHTS

May 2024

Cell therapy upstream processing and materials

Download PDF

Expert Insight

The sweet cell of success: key considerations for the sourcing and production of pluripotent cell lines for therapeutic development

The sweet cell of success: key considerations for the sourcing and production of pluripotent cell lines for therapeutic development

Samuel JI Blackford, Nathan C Manley

Raw materials and supplies for cell therapies: end to end expectations and best practices

Raw materials and supplies for cell therapies: end to end expectations and best practices

Innovator Insight

G-Rex bioreactors incubated in Heracell™ Vios™ CR CO2 Incubators help prevent cross contamination and bacterial contamination in cell and gene modified cell therapy production

G-Rex bioreactors incubated in Heracell™ Vios™ CR CO2 Incubators help prevent cross contamination and bacterial contamination in cell and gene modified cell therapy production

M Kay Bates, D Fick, J Schneider et al.

An automated 24-hour CAR-T manufacturing process

An automated 24-hour CAR-T manufacturing process

Expert Roundtable

iPSC-based therapy dilemmas explored: overcoming hurdles for future success

iPSC-based therapy dilemmas explored: overcoming hurdles for future success

M Carpenter, L Munsie, K Raineri et al.

Commentary

De-risking pluripotent stem cell therapies

De-risking pluripotent stem cell therapies

Stephen Sullivan, Ricardo Baptista

Viewpoint

Enabling affordable access to CAR-T cell and other cellular gene therapy products

Enabling affordable access to CAR-T cell and other cellular gene therapy products

R Orentas, Y Xiong, I Oparaocha et al.

Interview

Planning for success with an allogeneic Treg cell sourcing strategy

Planning for success with an allogeneic Treg cell sourcing strategy

Weighing up the pros and cons of adopting a piecemeal versus a full automation approach to cell therapy manufacture

Weighing up the pros and cons of adopting a piecemeal versus a full automation approach to cell therapy manufacture

Webinars

Maximizing process control and efficiency in CAR-T cell manufacturing

Maximizing process control and efficiency in CAR-T cell manufacturing

J Isaacson, M Ahmadi, R Jarres et al.

Think ahead: preparing for challenges to accelerate your cell therapy commercialization

Think ahead: preparing for challenges to accelerate your cell therapy commercialization

S Ghassemi, S Carmichael, K Henckels et al.

Revolutionary innovations are underway to industrialize cell and gene therapies

Revolutionary innovations are underway to industrialize cell and gene therapies

Mark Santos

Supporting efficacy and scaling with a next-generation T cell AOF formulation medium

Supporting efficacy and scaling with a next-generation T cell AOF formulation medium

Alan Gutowski, Joanna Kern